| 000 | 03160nam a22005055i 4500 | ||
|---|---|---|---|
| 001 | 246713 | ||
| 003 | IT-RoAPU | ||
| 005 | 20221215000243.0 | ||
| 006 | m|||||o||d|||||||| | ||
| 007 | cr || |||||||| | ||
| 008 | 191221s2019 gw fo d z eng d | ||
| 020 |
_a9783110133653 _qprint |
||
| 020 |
_a9783110851724 _qPDF |
||
| 024 | 7 |
_a10.1515/9783110851724 _2doi |
|
| 035 | _a(DE-B1597)9783110851724 | ||
| 035 | _a(DE-B1597)55354 | ||
| 035 | _a(OCoLC)1125188447 | ||
| 040 |
_aDE-B1597 _beng _cDE-B1597 _erda |
||
| 072 | 7 |
_aMED027000 _2bisacsh |
|
| 084 | _aonline - DeGruyter | ||
| 100 | 1 |
_aNortier, J. W. R. _eautore |
|
| 245 | 1 | 0 |
_aAdjunctive Medical Therapy for Acromegalic Patients / _cJ. W. R. Nortier. |
| 250 | _aReprint 2019 | ||
| 264 | 1 |
_aBerlin ; _aBoston : _bDe Gruyter Mouton, _c[2019] |
|
| 264 | 4 | _c©1984 | |
| 300 |
_a1 online resource (X, 91 p.) : _bNum. tables |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 0 |
_aClinical research series ; _v2 |
|
| 505 | 0 | 0 |
_tFrontmatter -- _tList of abbreviations -- _tContents -- _tCHAPTER I. Introduction -- _tCHAPTER II. Plasma growth hormone suppressive effect of bromocriptine in acromegaly. Evaluation by plasma GH day profiles and plasma GH concentrations during oral glucose tolerance tests / _rNortier, J.W.R. / Croughs, R.J.M. / Thijssen, J.H.H. / Schwarz, F. -- _tCHAPTER III. Changes in plasma GH levels and clinical activity during bromocriptine therapy in acromegaly. The value of predictive tests / _rNortier, J.W.R. / Croughs, R.J.M. / Donker, G.H. / Thijssen, J.H.H. / Schwarz, F. -- _tCHAPTER IV. Bromocriptine therapy in acromegaly: effects on plasma GH levels, somatomedin-C levels and clinical activity / _rNortier, J.W.R. / Croughs, R.J.M. / Thijssen, J.H.H. / Schwarz, F. -- _tCHAPTER V. Gel filtration studies of plasma growth hormone in bromocriptine treated acromegaly: correlations with somatomedin-C and clinical response / _rNortier, J.W.R. / Croughs, R.J.M. / Donker, G.H. / Thijssen, J.H.H. / Schwarz, F. -- _tCHAPTER VI. No acute effect of pimozide on the plasma GH levels in acromegaly / _rNortier, J.W.R. / Croughs, R.J.M. / Donker, G.H. / Thijssen, J.H.H. / Schwarz, F. -- _tCHAPTER VII. Long-term follow-up of five untreated acromegalic patients / _rNortier, J.W.R. / Croughs, R.J.M. / Thijssen, J.H.H. / Schwarz, F. -- _tCHAPTER VIII. General discussion -- _tSummary |
| 506 | 0 |
_arestricted access _uhttp://purl.org/coar/access_right/c_16ec _fonline access with authorization _2star |
|
| 538 | _aMode of access: Internet via World Wide Web. | ||
| 546 | _aIn English. | ||
| 588 | 0 | _aDescription based on online resource; title from PDF title page (publisher's Web site, viewed 21. Dez 2019) | |
| 650 | 4 | _aAcromegaly. | |
| 650 | 4 | _aBromocriptine -- Therapeutic use. | |
| 650 | 4 | _aSomatotropin. | |
| 650 | 7 |
_aMEDICAL / Endocrinology & Metabolism. _2bisacsh |
|
| 850 | _aIT-RoAPU | ||
| 856 | 4 | 0 | _uhttps://doi.org/10.1515/9783110851724 |
| 856 | 4 | 2 |
_3Cover _uhttps://www.degruyter.com/cover/covers/9783110851724.jpg |
| 942 | _cEB | ||
| 999 |
_c246713 _d246713 |
||